Press releases
Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.
2026
15 Jun 2026, 07:00
12 Jun 2026, 07:00
10 Jun 2026, 08:00
2 Jun 2026, 12:35
1 Jun 2026, 17:00 | Regulatory
29 May 2026, 07:00
27 May 2026, 07:12 | Regulatory
· The 1-year graft failure-free survival was 90%, which is clinically meaningful and supports full marketing authorization submission
· Idefirix was generally well tolerated with a safety profile consistent with previous clinical trial experience
· Submission to EMA for conversion to full marketing authorization planned for Q4 2026